Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Resverlogix reports results from phase I trial of apabetalone in severe kidney impairment

Jan. 24, 2017

Roche divulges novel DDR1 inhibitors

Jan. 20, 2017

Chongqing University reports PDE5A inhibitors

Jan. 13, 2017

Kissei Pharmaceutical describes TRPM8 antagonists

Jan. 12, 2017

Phase IIa study of SER-150 in diabetic nephropathy reaches primary endpoint

Jan. 5, 2017

Ardelyx initiates two new trials of RDX-7675 for hyperkalemia

Jan. 5, 2017

Vifor Pharma and ChemoCentryx expand kidney health alliance

Dec. 23, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

Third Rock Ventures launches Goldfinch Bio with a focus on therapies for kidney disease

Dec. 15, 2016

Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD

Dec. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...